...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: aberaterone
Reply New Message
Back To Forum List View
Icon president aberaterone
2
Toinv
Jun 24, 2018 01:32PM

Toinv, 

If I recall, both enzalutamide and abiratetone are currently approved for second line therapy. 

BearDownAZ 

3 Recommendations
Icon president Re: aberaterone
3
tada
Jun 25, 2018 12:25AM
Icon president Re: aberaterone
5
BearDownAZ
Jun 25, 2018 12:12PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply